fbpx Skip to main content

Takeda Pharmaceuticals U.S.A., Inc. ARTICLE

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

CSL and Takeda to Create Virus Plasma Treatment, J&J's COVID-19 Vaccine Trial to Begin in September, BD Offers Fingerstick Antibody Blood Test for COVID-19

  • Published on 6th, April 2020
  • California
  • Author: Lauren Panetta

4/6/20 - Financial Review
CSL Teams Up with Takeda to Create Virus Plasma Treatment

4/6/20 - FierceBiotech
GSK, AstraZeneca Considering Joint Diagnostics Lab: Bloomberg

4/6/20 - GEN
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration

4/6/20 - Gilead
Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery

4/6/20 - FierceBiotech
Pfizer Signs Up for Longer Pact with Icon

4/6/20 - STAT News
GlaxoSmithKline and Vir Aim to Take on Covid-19 with Antibodies and CRISPR

4/6/20 - Conatus Pharmaceuticals
Histogen Announces Investigational New Drug Application Amendment for HST 001

4/3/20 - UC San Diego
Online Civic Design Challenge to Help San Diego Address COVID-19

4/3/20 - Aradigm
Aradigm Announces Sale of Assets to Grifols, S.A.

4/3/20 - FierceBiotech
GSK Allies with Innovax for COVID-19 Vaccine R&D Project

4/3/20 - The San Diego Union-Tribune
Scripps Research Finds ‘Possible Achilles Heel’ in the Coronavirus

4/2/20 - FierceBiotech
BD to Offer Fingerstick Antibody Blood Test for COVID-19

4/2/20 - Gilead
Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma

4/2/20 - Ansun Biopharma
Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

4/2/20 - Persephone Biosciences
Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19

4/1/20 - Locana
Locana Expands Leadership Team with Appointment of Micah Mackison, as Chief Business Officer

3/31/20 - Thermo Fisher Scientific
Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)

3/31/20 - UC San Diego
Discovery of New Biomarker in Blood Could Lead to Early Test for Alzheimer’s Disease

3/31/20 - Sorrento Therapeutics
Sorrento and the University of Texas Medical Branch at Galveston: Preclinical Testing Agreement for COVID-19 Therapeutic Candidates

3/31/20 - Ultragenyx
REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder

3/30/20 - GEN
J&J Eyes September Trial for COVID-19 Vaccine, Commits to Expanded $1B+ BARDA Partnership

3/27/20 - GEN
Sanofi Expands COVID-19 Pipeline with Translate Bio Partnership